CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022
Operating expenses
Research and development	$ 21,821,255	$ 10,417,278	$ 43,349,593	$ 19,531,965
Selling, general and administrative	6,633,106	15,728,933	12,787,425	17,046,966
New Warrants expenses	0	87,352,000	0	87,352,000
Loss from operations	(28,454,361)	(113,498,211)	(56,137,018)	(123,930,931)
Change in fair value of derivative liabilities	(6,784,425)	5,842,500	(8,978,925)	5,842,500
Financial investment income	2,982,448	824,567	6,236,848	887,948
Other financial gain/(loss), net	1,149,332	(260,713)	2,173,822	98,618
Loss before income taxes	(31,107,006)	(107,091,857)	(56,705,273)	(117,101,865)
Income tax expense	(303,020)	(129,708)	(476,735)	(129,708)
Net loss	$ (31,410,026)	$ (107,221,565)	$ (57,182,008)	$ (117,231,573)
Net loss per share basic (in dollars per share)	$ (0.11)	$ (0.43)	$ (0.21)	$ (0.5)
Net loss per share diluted (in dollars per share)	$ (0.11)	$ (0.43)	$ (0.21)	$ (0.5)
Weighted-average number of shares outstanding – basic (in shares)	275,632,354	248,989,790	275,563,187	234,574,977
Weighted-average number of shares outstanding – diluted (in shares)	275,632,354	248,989,790	275,563,187	234,574,977